The estimated Net Worth of Ronald W Kaiser is at least $1.29 Million dollars as of 6 June 2012. Ronald Kaiser owns over 10,000 units of Opiant Pharmaceuticals Inc stock worth over $1,032,500 and over the last 21 years Ronald sold OPNT stock worth over $260,800.
Ronald has made over 3 trades of the Opiant Pharmaceuticals Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Ronald exercised 10,000 units of OPNT stock worth $132,500 on 6 June 2012.
The largest trade Ronald's ever made was exercising 35,000 units of Opiant Pharmaceuticals Inc stock on 29 November 2010 worth over $421,050. On average, Ronald trades about 3,929 units every 40 days since 2003. As of 6 June 2012 Ronald still owns at least 50,000 units of Opiant Pharmaceuticals Inc stock.
You can see the complete history of Ronald Kaiser stock trades at the bottom of the page.
Ronald's mailing address filed with the SEC is C/O OPNET TECHNOLOGIES, INC., 7255 WOODMONT AVENUE, BETHESDA, MD, 20814.
Over the last 21 years, insiders at Opiant Pharmaceuticals Inc have traded over $16,027,532 worth of Opiant Pharmaceuticals Inc stock and bought 199,545 units worth $2,080,156 . The most active insiders traders include Craig A Collard, Marc A Cohen, and Alain J Cohen. On average, Opiant Pharmaceuticals Inc executives and independent directors trade stock every 23 days with the average trade being worth of $159,046. The most recent stock trade was executed by Roger Crystal on 27 January 2023, trading 1,358 units of OPNT stock currently worth $27,513.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Opiant Pharmaceuticals Inc executives and other stock owners filed with the SEC include: